Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Autors principals: Xiao-yi Bao (Autor), Qun Zheng (Autor), Qiang Tong (Autor), Peng-chong Zhu (Autor), Zhuang Zhuang (Autor), Guo-qing Zheng (Autor), Yan Wang (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...